Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Revenue
Product sales	$ 891,472	$ 1,045,080
Cost of product sales	279,687	440,668
Gross profit from product sales	611,785	604,412
Other Revenue
Retained royalties	34,748	27,782
Other income	69,304	90,776
Total other revenue	104,052	118,558
Operating expenses
Selling expenses	250,995	213,419
Personnel and consulting expenses	1,700,166	1,368,299
General and administrative expenses	1,463,396	1,371,035
Total operating expenses	3,414,557	2,952,753
Operating loss	(2,698,720)	(2,229,783)
Other expense (income)
Interest expense	$ 976,774	964,070
Interest expense - accelerated upon conversion of OID notes		35,109
Loss on conversion of notes	$ 2,588	63,867
Loss on settlement of note and warrant		132,301
Unrealized gain on derivative instruments		(14,231)
Total other expense	$ 979,362	1,181,116
Loss before income taxes	$ (3,678,082)	$ (3,410,899)
Provision (benefit) for income taxes
Net loss	$ (3,678,082)	$ (3,410,899)
Basic and diluted loss per share	$ (0.13)	$ (0.15)
Basic and diluted weighted average number of common shares outstanding:	27,885,238	23,513,870